Position in BMY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,292,646
+$146,241 QoQ
Shares Held
22,434
+18.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,029
of 2,505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. BMY ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,271 | $792,278 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,292,646 | 22,434 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $1,146,405 | 18,902 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $1,002,636 | 18,588 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $815,317 | 18,078 | Shares | Defined | 2025-10-06 | |
| 2025-06-30 | $903,997 | 19,529 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $1,153,320 | 18,910 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $1,049,188 | 18,550 | Shares | Defined | 2025-01-16 | |
| 2024-09-30 | $835,238 | 16,143 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $618,921 | 14,903 | Shares | Defined | 2024-07-24 | |
| 2024-03-31 | $706,779 | 13,033 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $247,057 | 4,815 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $311,326 | 5,364 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $400,007 | 6,255 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $426,741 | 6,157 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $405,078 | 5,630 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $882,582 | 12,415 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $890,967 | 11,571 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $908,493 | 12,440 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $515,385 | 8,266 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $456,851 | 7,721 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $515,984 | 7,722 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $490,141 | 7,764 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $611,739 | 9,862 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $531,154 | 8,810 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $431,356 | 7,336 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $318,832 | 5,720 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||